Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Change in Receivables (2026)

Updated

Global Innovative Platforms' Change in Receivables came in at -$3,300 for fiscal Q3 2026 (quarter ended Jun 30, 2026).

Analysis

Global Innovative Platforms (GIPL) Change in Receivables (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 1.35 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 1.37 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 333.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 140.20 Mn
10 Global Innovative Platforms 24.88 Mn 24.27 Mn - -3,300.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,300.00
API Access

Global Innovative Platforms Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=GIPL&period=max&api_key=YOUR_API_KEY